Award
NIH Reporter #1R43CA298411-01A1
Functional signatures of post-infusion CAR T cells for early indication of patient response
Recipient
CELLCHORUS INC.
Award Amount
$399,625.00
Ceiling
$399,625.00
Awarded
August 21, 2025
Identifier
1R43CA298411-01A1
NIH-funded project to develop predictive signatures for CAR T cell therapy response using advanced live-cell imaging and AI analysis.
Description
This project aims to develop a functional signature associated with patient response to CAR T cell therapy in relapsed/refractory large B cell lymphoma (r/rLBCL). Using Time-lapse Imaging Microscopy In Nanowell Grids (TIMING™), the study will profile post-infusion CAR-T cells to identify early predictors of treatment response, facilitating better treatment planning and response assessment.